Here's Why Innoviva Inc. Lost 10% Today

What happened Shares of Innoviva NASDAQ INVA a biotechnology royalty company that develops respiratory therapeutics and is perhaps best known as GlaxoSmithKline s NYSE GSK development partner for its multiple next generation COPD and asthma products fell as much as